유럽 장관 영양 시장 규모 및 예측(2021-2031), 지역 점유율, 추세 및 성장 기회 분석 보고서 범위: 제품 유형(비강위관, 비강장관, 시핑 및 기타) 및 국가별
표준화된 제형과 식물성 영양 제품
특히 에너지 수준, 면역 및 질병 치료 측면에서 특정 요구 사항에 초점을 맞춘 소비자가 건강을 적극적으로 관리하는 데 도움이 되는 제품에 대한 수요가 급증하고 있습니다. 장관 제품의 기능성과 특정 제형은 환자의 기존 치료를 방해하지 않습니다. 장관 영양의 거대 영양소 및 미량 영양소 제형과 그 응용 분야는 고려 중인 질병에 따라 다릅니다. 등칼로리 장내 영양 제형(1kcal/ml)은 일반적으로 추정 또는 측정된 칼로리 목표를 달성하기 위해 처방되는 반면, 에너지 밀도가 높은 제형(>1kcal/ml)은 위장 장애가 있는 환자의 칼로리 전달을 늘리기 위해 처방됩니다.
표준화된 장내 영양 제품은 고정된 성분을 함유하고 있으며 연령대마다 요구 사항이 다르다는 점을 고려하여 환자의 평균 영양 요구 사항을 충족하도록 설계되었습니다. 예를 들어, Peptamen Formula(Nestle)는 튜브 수유 불내증을 극복하는 데 도움이 되는 효소 가수분해된 100% 유청 단백질이 포함된 유일한 펩타이드 기반 제형입니다. 이러한 튜브 수유 제형은 위장 장애가 있는 개인의 흡수를 지원하고 내성 메커니즘을 극복하도록 설계된 특수 장내 영양 제품입니다.
식물성 식품을 섭취하는 사람의 수가 급증함에 따라 전 세계적으로 식물성 영양 제품에 대한 수요가 증가하고 있습니다. 사람들은 더 많은 수로 사용되는 인공/합성 원료에 대한 불내증이 점점 더 심해지고 있으며, 이는 부작용으로 이어질 수 있습니다. Innova Consumer Survey 2020에 따르면 건강, 다양한 식단, 지속 가능성, 맛이 사람들이 식물성 대체 식품을 고려하는 가장 큰 이유 중 하나입니다. Abbott은 튜브 영양 공급에 의존하는 소비자와 환자도 이러한 매개변수에 많은 관심을 기울인다고 말합니다. 유럽 장관 영양 시장의 회사들은 다양한 인구통계 그룹에서 건강식품에 대한 선호도가 높아지는 것을 활용하고 있습니다. 그 결과 Kate Farms, Functional Formularies, Real Food Blends와 같은 회사들은 보다 자연스럽고 식물성 장관 제품을 개발했습니다. 2021년 8월, Kate Farms는 1L 용량의 바로 걸 수 있는 백에 식물성 제형을 제공하는 최초의 폐쇄형 공급 시스템을 출시했습니다. Kate Farms Standard 1.4 일반 및 Peptide 1.5 일반 제형은 튜브 영양 공급에서 보충 영양의 유일한 공급원으로 사용되는 식물성, 유기농, 열량이 높은 제품입니다. 2021년 9월, Abbott은 어린이와 성인을 위한 식물성 단백질과 유기농 식품 성분 포트폴리오를 출시했습니다.
따라서 기능적이고 환자 중심적인 제형과 식물성 영양 제품이 유럽 장관영양 시장에서 떠오르는 주요 트렌드입니다.
프랑스 장관영양 시장 분석
2023년 3월에 발표된 Le Monde 기사에 따르면, 프랑스에서 60세 이상의 인구 비중은 2023년의 약 20%에서 2050년까지 약 30%로 급증할 것으로 예상됩니다. 85세 이상의 인구는 2030~2050년 동안 거의 90% 증가할 것입니다. 노인은 종종 당뇨병, 심혈관 질환, 신경계 질환(예: 뇌졸중, 파킨슨병, 알츠하이머병)과 같은 만성 질환을 겪습니다. 이러한 질환은 정상적으로 먹는 능력을 손상시켜 영양실조로 이어지고 장관영양이 필요할 수 있습니다. Global Cancer Observatory에 따르면 프랑스는 2022년에 483,568건의 새로운 암 사례를 보고했으며, 유병률(5년)은 1,494,814건이었습니다. 암과 장관 영양은 밀접하게 연결되어 있습니다. 많은 암 환자가 질병 자체 또는 받는 치료로 인해 영양실조에 시달리며, 이는 필수 영양소를 섭취하고 흡수하는 능력을 손상시킬 수 있습니다.
Fresenius Kabir France는 튜브 공급, 경구 영양 보충제(ONS), 분말 제품과 같은 다양한 기성 장관 영양 제품 포트폴리오를 제공합니다. 삼키기 곤란증이 있는 환자의 경우, 이 회사는 다양한 환자의 개별적인 요구를 충족시키기 위해 다양한 농도의 질감이 변형된 제품을 제공합니다.
유럽 장관 영양 시장 보고서 세분화 분석
유럽 장관 영양 시장 분석의 도출에 기여한 주요 세그먼트는 유형, 재료 및 최종 사용자입니다.
제품 유형에 따라 유럽 장관 영양 시장은 비강위장, 비강장관, 시핑 및 기타로 세분화됩니다. 비강위장 부문은 2023년에 시장에서 가장 큰 점유율을 차지했습니다.
유럽 장관 영양 시장에서 활동하는 몇몇 저명한 기업으로는 Nestlé, Danone SA, Abbott Laboratories, Friesland Campina, Fresenius SE and Co. KGaA, B. Braun SE, Dr. Schär AG, Arla Food, Reckitt Benckiser, Perrigo Company PLC, Fonterra Co-operative Group Limited, Kate Farms, Nutritional Medicinals, LLC 등이 있습니다.
기업들은 유럽 장관 영양 시장 규모에서 자사의 입지를 유지하기 위해 새롭고 혁신적인 제품과 서비스를 출시하고 있습니다. Abbott은 2021년 11월에 면역 체계, 소화 건강 및 뇌 발달을 지원하기 위해 Similac 360 Total Care를 출시했습니다. Similac 360 Total Care는 이전에는 모유에서만 발견되었던 다섯 가지 다른 HMO를 혼합한 미국 최초이자 유일한 영유아용 조제분유입니다. 이 조제분유는 발달하는 면역 체계, 소화 체계, 뇌를 포함하여 아기의 건강과 발달을 지원하는 영양을 제공하도록 설계되었습니다.
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:
4. Europe Enteral Nutrition Market Landscape
4.1 Overview
4.2 PEST Analysis
4.3 Pricing Analysis
4.4 Pricing Analysis for Sipping Formula
4.5 List of Key Market Players in Top 5 Market
4.5.1 Major Market players in Germany, France, United Kingdom
5. Europe Enteral Nutrition Market – Key Market Dynamics
5.1 Europe Enteral Nutrition Market – Key Market Dynamics
5.2 Market Drivers
5.2.1 Increasing Prevalence of Gastrointestinal Diseases
5.2.2 Rising Cases of Malnutrition and Premature Births
5.3 Market Restraints
5.3.1 Mechanical, Gastrointestinal, and Metabolic Complications Associated with Feeding Systems
5.4 Market Opportunities
5.4.1 Strategic Initiatives by Key Market Players
5.5 Future Trends
5.5.1 Standardized Formulations and Plant-Based Nutrition Products
5.6 Impact of Drivers and Restraints:
6. Europe Enteral Nutrition Market Analysis
6.1 Europe Enteral Nutrition Market Revenue (US$ Million), 2021–2031
6.2 Europe Enteral Nutrition Market Forecast and Analysis
6.3 Enteral and Parenteral Market Value (%)
7. Europe Enteral Nutrition Market Analysis – by Product Type
7.1 Nasogastric
7.1.1 Overview
7.1.2 Nasogastric: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
7.1.3 Standard
7.1.3.1 Overview
7.1.3.2 Standard: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
7.1.4 Disease Specific
7.1.4.1 Overview
7.1.4.2 Disease Specific: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Nasoenteral
7.2.1 Overview
7.2.2 Nasoenteral: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Sipping
7.3.1 Overview
7.3.2 Sipping: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Others
7.4.1 Overview
7.4.2 Others: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
8. Europe Enteral Nutrition Market – Country Analysis
8.1 Europe
8.1.1 Europe Enteral Nutrition Market Breakdown by Countries
8.1.2 Europe Enteral Nutrition Market Revenue and Forecast and Analysis – by Country
8.1.2.1 Europe Enteral Nutrition Market Revenue and Forecast and Analysis – by Country
8.1.2.2 Germany: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
8.1.2.2.1 Germany: Europe Enteral Nutrition Market Breakdown by Product Type
8.1.2.2.2 Germany: Europe Enteral Nutrition Market Breakdown by Nasogastric Type
8.1.2.2.3 Germany: Europe Enteral Nutrition Market Breakdown by Standard By Calories
8.1.2.2.4 Germany: Europe Enteral Nutrition Market Breakdown by Isocaloric
8.1.2.2.5 Germany: Europe Enteral Nutrition Market Breakdown by Hypercaloric
8.1.2.2.6 Germany: Europe Enteral Nutrition Market Breakdown by Standard By Type
8.1.2.2.7 Germany: Europe Enteral Nutrition Market Breakdown by Standard By End User
8.1.2.3 United Kingdom: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
8.1.2.3.1 United Kingdom: Europe Enteral Nutrition Market Breakdown by Product Type
8.1.2.3.2 United Kingdom: Europe Enteral Nutrition Market Breakdown by Nasogastric Type
8.1.2.3.3 United Kingdom: Europe Enteral Nutrition Market Breakdown by Standard By Calories
8.1.2.3.4 United Kingdom: Europe Enteral Nutrition Market Breakdown by Isocaloric
8.1.2.3.5 United Kingdom: Europe Enteral Nutrition Market Breakdown by Hypercaloric
8.1.2.3.6 United Kingdom: Europe Enteral Nutrition Market Breakdown by Standard By Type
8.1.2.3.7 United Kingdom: Europe Enteral Nutrition Market Breakdown by Standard By End User
8.1.2.4 France: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
8.1.2.4.1 France: Europe Enteral Nutrition Market Breakdown by Product Type
8.1.2.4.2 France: Europe Enteral Nutrition Market Breakdown by Nasogastric Type
8.1.2.4.3 France: Europe Enteral Nutrition Market Breakdown by Standard By Calories
8.1.2.4.4 France: Europe Enteral Nutrition Market Breakdown by Isocaloric
8.1.2.4.5 France: Europe Enteral Nutrition Market Breakdown by Hypercaloric
8.1.2.4.6 France: Europe Enteral Nutrition Market Breakdown by Standard By Type
8.1.2.4.7 France: Europe Enteral Nutrition Market Breakdown by Standard By End User
8.1.2.5 Italy: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
8.1.2.5.1 Italy: Europe Enteral Nutrition Market Breakdown by Product Type
8.1.2.5.2 Italy: Europe Enteral Nutrition Market Breakdown by Nasogastric Type
8.1.2.5.3 Italy: Europe Enteral Nutrition Market Breakdown by Standard By Calories
8.1.2.5.4 Italy: Europe Enteral Nutrition Market Breakdown by Isocaloric
8.1.2.5.5 Italy: Europe Enteral Nutrition Market Breakdown by Hypercaloric
8.1.2.5.6 Italy: Europe Enteral Nutrition Market Breakdown by Standard By Type
8.1.2.5.7 Italy: Europe Enteral Nutrition Market Breakdown by Standard By End User
8.1.2.6 Spain: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
8.1.2.6.1 Spain: Europe Enteral Nutrition Market Breakdown by Product Type
8.1.2.6.2 Spain: Europe Enteral Nutrition Market Breakdown by Nasogastric Type
8.1.2.6.3 Spain: Europe Enteral Nutrition Market Breakdown by Standard By Calories
8.1.2.6.4 Spain: Europe Enteral Nutrition Market Breakdown by Isocaloric
8.1.2.6.5 Spain: Europe Enteral Nutrition Market Breakdown by Hypercaloric
8.1.2.6.6 Spain: Europe Enteral Nutrition Market Breakdown by Standard By Type
8.1.2.6.7 Spain: Europe Enteral Nutrition Market Breakdown by Standard By End User
8.1.2.7 Czech Republic: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
8.1.2.7.1 Czech Republic: Europe Enteral Nutrition Market Breakdown by Product Type
8.1.2.7.2 Czech Republic: Europe Enteral Nutrition Market Breakdown by Nasogastric Type
8.1.2.7.3 Czech Republic: Europe Enteral Nutrition Market Breakdown by Standard By Calories
8.1.2.7.4 Czech Republic: Europe Enteral Nutrition Market Breakdown by Isocaloric
8.1.2.7.5 Czech Republic: Europe Enteral Nutrition Market Breakdown by Hypercaloric
8.1.2.7.6 Czech Republic: Europe Enteral Nutrition Market Breakdown by Standard By Type
8.1.2.7.7 Czech Republic: Europe Enteral Nutrition Market Breakdown by Standard By End User
8.1.2.8 Rest of Europe: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
8.1.2.8.1 Rest of Europe: Europe Enteral Nutrition Market Breakdown by Product Type
8.1.2.8.2 Rest of Europe: Europe Enteral Nutrition Market Breakdown by Nasogastric Type
8.1.2.8.3 Rest of Europe: Europe Enteral Nutrition Market Breakdown by Standard By Calories
8.1.2.8.4 Rest of Europe: Europe Enteral Nutrition Market Breakdown by Isocaloric
8.1.2.8.5 Rest of Europe: Europe Enteral Nutrition Market Breakdown by Hypercaloric
8.1.2.8.6 Rest of Europe: Europe Enteral Nutrition Market Breakdown by Standard By Type
8.1.2.8.7 Rest of Europe: Europe Enteral Nutrition Market Breakdown by Standard By End User
9. Industry Landscape
9.1 Overview
9.2 Growth Strategies in Europe Enteral Nutrition Market
9.3 Organic Growth Strategies
9.3.1 Overview
9.4 Inorganic Growth Strategies
9.4.1 Overview
10. Company Profiles
10.1 Nestle SA
10.1.1 Key Facts
10.1.2 Business Description
10.1.3 Products and Services
10.1.4 Financial Overview
10.1.5 SWOT Analysis
10.1.6 Key Developments
10.2 Danone SA
10.2.1 Key Facts
10.2.2 Business Description
10.2.3 Products and Services
10.2.4 Financial Overview
10.2.5 SWOT Analysis
10.2.6 Key Developments
10.3 Abbott Laboratories
10.3.1 Key Facts
10.3.2 Business Description
10.3.3 Products and Services
10.3.4 Financial Overview
10.3.5 SWOT Analysis
10.3.6 Key Developments
10.4 Royal FrieslandCampina NV
10.4.1 Key Facts
10.4.2 Business Description
10.4.3 Products and Services
10.4.4 Financial Overview
10.4.5 SWOT Analysis
10.4.6 Key Developments
10.5 Fresenius SE & Co KGaA
10.5.1 Key Facts
10.5.2 Business Description
10.5.3 Products and Services
10.5.4 Financial Overview
10.5.5 SWOT Analysis
10.5.6 Key Developments
10.6 B Braun SE
10.6.1 Key Facts
10.6.2 Business Description
10.6.3 Products and Services
10.6.4 Financial Overview
10.6.5 SWOT Analysis
10.6.6 Key Developments
10.7 Reckitt Benckiser Group Plc
10.7.1 Key Facts
10.7.2 Business Description
10.7.3 Products and Services
10.7.4 Financial Overview
10.7.5 SWOT Analysis
10.7.6 Key Developments
10.8 Kate Farms Inc
10.8.1 Key Facts
10.8.2 Business Description
10.8.3 Products and Services
10.8.4 Financial Overview
10.8.5 SWOT Analysis
10.8.6 Key Developments
10.9 Dr Schar AG
10.9.1 Key Facts
10.9.2 Business Description
10.9.3 Products and Services
10.9.4 Financial Overview
10.9.5 SWOT Analysis
10.9.6 Key Developments
10.10 Fonterra Co-Operative Group Ltd
10.10.1 Key Facts
10.10.2 Business Description
10.10.3 Products and Services
10.10.4 Financial Overview
10.10.5 SWOT Analysis
10.10.6 Key Developments
10.11 Arla Foods amba
10.11.1 Key Facts
10.11.2 Business Description
10.11.3 Products and Services
10.11.4 Financial Overview
10.11.5 SWOT Analysis
10.11.6 Key Developments
10.12 Perrigo Co Plc
10.12.1 Key Facts
10.12.2 Business Description
10.12.3 Products and Services
10.12.4 Financial Overview
10.12.5 SWOT Analysis
10.12.6 Key Developments
10.13 Charing Cross Scientific AS
10.13.1 Key Facts
10.13.2 Business Description
10.13.3 Products and Services
10.13.4 Financial Overview
10.13.5 SWOT Analysis
10.13.6 Key Developments
10.14 Bexen Medical
10.14.1 Key Facts
10.14.2 Business Description
10.14.3 Products and Services
10.14.4 Financial Overview
10.14.5 SWOT Analysis
10.14.6 Key Developments
11. Appendix
11.1 About The Insight Partners
11.2 Glossary of Terms
List of Tables
Table 1. Europe Enteral Nutrition Market Segmentation
Table 2. Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
Table 3. Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Product Type
Table 4. Sipping: Europe Enteral Nutrition Market, By Type (US$ Mn)
Table 5. Sipping: Europe Enteral Nutrition Market, By Standadr by Calories (US$ Mn)
Table 6. Sipping: Europe Enteral Nutrition Market, By Isocaloric (US$ Mn)
Table 7. Sipping: Europe Enteral Nutrition Market, By Hypercaloric (US$ Mn)
Table 8. Sipping: Europe Enteral Nutrition Market, By Standard by Type (US$ Mn)
Table 9. Sipping: Europe Enteral Nutrition Market, By Standard End User (US$ Mn)
Table 10. Sipping: Top 5 Europe Enteral Nutrition Markets (US$ Mn)
Table 11. Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Country
Table 12. Germany: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Product Type
Table 13. Germany: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Nasogastric Type
Table 14. Germany: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Standard By Calories
Table 15. Germany: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Isocaloric
Table 16. Germany: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Hypercaloric
Table 17. Germany: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Standard By Type
Table 18. Germany: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Standard By End User
Table 19. United Kingdom: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Product Type
Table 20. United Kingdom: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Nasogastric Type
Table 21. United Kingdom: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Standard By Calories
Table 22. United Kingdom: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Isocaloric
Table 23. United Kingdom: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Hypercaloric
Table 24. United Kingdom: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Standard By Type
Table 25. United Kingdom: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Standard By End User
Table 26. France: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Product Type
Table 27. France: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Nasogastric Type
Table 28. France: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Standard By Calories
Table 29. France: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Isocaloric
Table 30. France: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Hypercaloric
Table 31. France: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Standard By Type
Table 32. France: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Standard By End User
Table 33. Italy: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Product Type
Table 34. Italy: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Nasogastric Type
Table 35. Italy: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Standard By Calories
Table 36. Italy: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Isocaloric
Table 37. Italy: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Hypercaloric
Table 38. Italy: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Standard By Type
Table 39. Italy: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Standard By End User
Table 40. Spain: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Product Type
Table 41. Spain: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Nasogastric Type
Table 42. Spain: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Standard By Calories
Table 43. Spain: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Isocaloric
Table 44. Spain: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Hypercaloric
Table 45. Spain: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Standard By Type
Table 46. Spain: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Standard By End User
Table 47. Czech Republic: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Product Type
Table 48. Czech Republic: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Nasogastric Type
Table 49. Czech Republic: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Standard By Calories
Table 50. Czech Republic: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Isocaloric
Table 51. Czech Republic: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Hypercaloric
Table 52. Czech Republic: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Standard By Type
Table 53. Czech Republic: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Standard By End User
Table 54. Rest of Europe: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Product Type
Table 55. Rest of Europe: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Nasogastric Type
Table 56. Rest of Europe: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Standard By Calories
Table 57. Rest of Europe: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Isocaloric
Table 58. Rest of Europe: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Hypercaloric
Table 59. Rest of Europe: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Standard By Type
Table 60. Rest of Europe: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Standard By End User
Table 61. Recent Organic Growth Strategies in Europe Enteral Nutrition Market
Table 62. Recent Inorganic Growth Strategies in the Europe Enteral Nutrition Market
Table 63. Glossary of Terms, Europe Enteral Nutrition Market
List of Figures
Figure 1. Europe Enteral Nutrition Market Segmentation, by Country
Figure 2. PEST Analysis
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Europe Enteral Nutrition Market Revenue (US$ Million), 2021–2031
Figure 5. Europe Enteral Nutrition Market Share (%) – by Product Type, 2023 and 2031
Figure 6. Nasogastric: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
Figure 7. Standard: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
Figure 8. Disease Specific: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
Figure 9. Nasoenteral: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
Figure 10. Sipping: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
Figure 11. Others: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
Figure 12. Europe Enteral Nutrition Market Breakdown by Key Countries, 2023 and 2031 (%)
Figure 13. Germany: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
Figure 14. United Kingdom: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
Figure 15. France: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
Figure 16. Italy: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
Figure 17. Spain: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
Figure 18. Czech Republic: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
Figure 19. Rest of Europe: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
Figure 20. Growth Strategies in Europe Enteral Nutrition Market
- Nestlé
- Danone S.A.
- Abbott Laboratories
- FrieslandCampina
- Fresenius SE and Co. KGaA
- B. Braun SE
- Dr. Schär AG
- Arla Food
- Reckitt Benckiser
- Perrigo Company PLC
- Fonterra Co-operative Group Limited
- Kate Farms
- Nutritional Medicinals, LLC
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe enteral nutrition market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Europe enteral nutrition market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution